Incidence of the V600K mutation among melanoma patients with BRAF mutations, and potential therapeutic response to the specific BRAF inhibitor PLX4032

Overview of attention for article published in Journal of Translational Medicine, July 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (91st percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 1 news outlet
patent: 3 patents

googleplus: 1 Google+ user

Citations

dimensions_citation: 209 Dimensions

Readers on

mendeley: 165 Mendeley

Summary News Patents Google+ Dimensions citations

So far, Altmetric has seen 3 patents that reference this research output.

CRYSTALLINE SALTS OF A B-RAF KINASE INHIBITOR

Application EP-4245758-A2

European Patent Office

CRYSTALLINE SALTS OF A B-RAF KINASE INHIBITOR

Application WO-2019084459-A1

World Intellectual Property Organisation (WIPO)

A METHOD TO DETERMINE BRAF MUTATIONS AND WILD TYPE BRAF PROTEIN BY MASS SPECTROMETRY

Application WO-2018114953-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.